Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole

Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole

Phyllis M Salzman,1 Arash Raoufinia,2 Susan Legacy,3 Pedro Such,4 Anna Eramo5 1Global Medical Affairs, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, 2Clinical Pharmacology, Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Salzman PM, Raoufinia A, Legacy S, Such P, Eramo A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
long-acting injectable
aripiprazole
plasma concentrations
dosing
schizophrenia
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/ca5b79ce43c04b4b963ea261d0ea7795
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/ca5b79ce43c04b4b963ea261d0ea7795

Ejemplares similares